NCT01749397 2020-07-02Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube CancerNational Cancer Institute (NCI)Phase 1 Completed29 enrolled